HRP20140804T1 - Konjugati koji obuhvaä†aju nanoäśestice obložene tvarima koje sadrže platinu - Google Patents

Konjugati koji obuhvaä†aju nanoäśestice obložene tvarima koje sadrže platinu Download PDF

Info

Publication number
HRP20140804T1
HRP20140804T1 HRP20140804AT HRP20140804T HRP20140804T1 HR P20140804 T1 HRP20140804 T1 HR P20140804T1 HR P20140804A T HRP20140804A T HR P20140804AT HR P20140804 T HRP20140804 T HR P20140804T HR P20140804 T1 HRP20140804 T1 HR P20140804T1
Authority
HR
Croatia
Prior art keywords
formula
conjugate
linker
platinum
iii
Prior art date
Application number
HRP20140804AT
Other languages
English (en)
Croatian (hr)
Inventor
Victor Franco Puntes
Fernando DOMÍNGUEZ PUENTE
Francisco Manuel ROMERO MARTÍNEZ
Óscar GALLEGO RUBIO
Original Assignee
Fundació Privada Institut Català De Nanotecnologia
Institució Catalana De Recerca I Estudis Avançats
Universidade De Santiago De Compostela
Universidad De Valencia
Fundació Privada Institut De Recerca De L'hospital De La Santa Creu I Sant Pau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundació Privada Institut Català De Nanotecnologia, Institució Catalana De Recerca I Estudis Avançats, Universidade De Santiago De Compostela, Universidad De Valencia, Fundació Privada Institut De Recerca De L'hospital De La Santa Creu I Sant Pau filed Critical Fundació Privada Institut Català De Nanotecnologia
Publication of HRP20140804T1 publication Critical patent/HRP20140804T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Powder Metallurgy (AREA)
HRP20140804AT 2008-12-16 2009-12-15 Konjugati koji obuhvaä†aju nanoäśestice obložene tvarima koje sadrže platinu HRP20140804T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08171870 2008-12-16
PCT/EP2009/067136 WO2010069941A1 (en) 2008-12-16 2009-12-15 Conjugates comprising nanoparticles coated with platinum containing compounds

Publications (1)

Publication Number Publication Date
HRP20140804T1 true HRP20140804T1 (hr) 2014-11-07

Family

ID=40568646

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20140804AT HRP20140804T1 (hr) 2008-12-16 2009-12-15 Konjugati koji obuhvaä†aju nanoäśestice obložene tvarima koje sadrže platinu

Country Status (13)

Country Link
US (1) US9023370B2 (https=)
EP (1) EP2379114B1 (https=)
JP (1) JP5873719B2 (https=)
CA (1) CA2745972C (https=)
CY (1) CY1115601T1 (https=)
DK (1) DK2379114T3 (https=)
ES (1) ES2505890T3 (https=)
HR (1) HRP20140804T1 (https=)
IL (1) IL213408A (https=)
PL (1) PL2379114T3 (https=)
PT (1) PT2379114E (https=)
SI (1) SI2379114T1 (https=)
WO (1) WO2010069941A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0909435D0 (en) * 2009-06-02 2009-07-15 Univ Strathclyde Nanoparticle for biomolecule delivery
ES2392528B1 (es) * 2010-12-28 2013-10-21 Endor Nanotechnologies, S.L. Sistema de liberación de agente terapéutico, composiciones farmacéuticas que lo contienen, su preparación y su uso médico.
ITRM20130138A1 (it) 2013-03-07 2014-09-08 Consiglio Nazionale Ricerche Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica
JP6316011B2 (ja) * 2014-02-04 2018-04-25 国立大学法人滋賀医科大学 抗癌剤が担持されたナノ粒子
US11007276B2 (en) * 2016-01-29 2021-05-18 National University Corporation Hokkaido University Intracellular substance transport system and use thereof
PL236093B1 (pl) 2017-07-04 2020-11-30 Dominika Szczepaniak Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie
ES2924863T3 (es) 2019-01-08 2022-10-11 Nanonica S A Conjugados que comprenden nanopartículas recubiertas con derivados de platino a través de enlazadores que contienen sulfonilo o fosfonilo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851932B (https=) 1984-08-14 1985-12-13 Engelhard Corp
JP2866554B2 (ja) 1992-08-25 1999-03-08 松下電器産業株式会社 情報記録媒体とその製造方法及び情報記録媒体の使用方法
WO2003101425A2 (en) 2002-06-03 2003-12-11 Alnis Biosciences, Inc. Therapeutic agent-containing polymeric nanoarticles
WO2006037081A2 (en) * 2004-09-28 2006-04-06 The Regents Of The University Of California Nanoparticle radiosensitizers
US7601331B2 (en) 2004-11-10 2009-10-13 National University Of Singapore NIR-sensitive nanoparticle
US20060222595A1 (en) * 2005-03-31 2006-10-05 Priyabrata Mukherjee Nanoparticles for therapeutic and diagnostic applications
US8785505B2 (en) * 2005-10-28 2014-07-22 The Regents Of The University Of California Toxicology and cellular effect of manufactured nanomaterials

Also Published As

Publication number Publication date
CY1115601T1 (el) 2017-01-04
JP2012512149A (ja) 2012-05-31
WO2010069941A1 (en) 2010-06-24
EP2379114A1 (en) 2011-10-26
US9023370B2 (en) 2015-05-05
DK2379114T3 (da) 2014-09-29
US20110262500A1 (en) 2011-10-27
PT2379114E (pt) 2014-10-06
IL213408A0 (en) 2011-07-31
CA2745972C (en) 2016-11-01
ES2505890T3 (es) 2014-10-10
IL213408A (en) 2017-06-29
CA2745972A1 (en) 2010-06-24
SI2379114T1 (sl) 2014-11-28
JP5873719B2 (ja) 2016-03-01
PL2379114T3 (pl) 2014-12-31
EP2379114B1 (en) 2014-07-09

Similar Documents

Publication Publication Date Title
HRP20140804T1 (hr) Konjugati koji obuhvaä†aju nanoäśestice obložene tvarima koje sadrže platinu
Otvagin et al. Synthesis and biological evaluation of new water-soluble photoactive chlorin conjugate for targeted delivery
JP2012512149A5 (https=)
CY1112362T1 (el) Πολυμερη βασιζομενα σε κυκλοδεξτρινη για χορηγηση των θεραπευτικων μεσων που ειναι ομοιοπολικως δεσμευμενα σε αυτα
Fumagalli et al. Self-assembly drug conjugates for anticancer treatment
Battogtokh et al. Mitochondrial-targeted photosensitizer-loaded folate-albumin nanoparticle for photodynamic therapy of cancer
JP6404925B2 (ja) グリコサミノグリカン化合物、その調製方法および使用
RU2013117441A (ru) Пролекарства, содержащие конъюгат эксендин-линкер
JP2012255007A5 (https=)
AU2006274992B2 (en) Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
CN116813631A (zh) 一种喜树碱类化合物及其偶联物
JP2012528240A5 (https=)
HRP20241783T1 (hr) Anti-her2 antitijelo-lijek konjugat
JP7764041B2 (ja) 脳腫瘍における改善された血液脳関門浸透性及び滞留性を備えた、スケーラブルなチロインテグリンアンタゴニストの組成物
CO2024006160A2 (es) Conjugado de anticuerpo bispecífico-fármaco de camptotecina y uso farmacéutico de este
WO2020160222A3 (en) Conjugates of bivalent evans blue dye derivatives and methods of use
EA023248B1 (ru) Фармацевтические субстанции на основе митохондриально-адресованных антиоксидантов
Thomas et al. Dendrimer-based tumor cell targeting of fibroblast growth factor-1
US10011587B2 (en) Multivalent ligands targeting VEGFR
JP2010528122A5 (https=)
JP2017226851A (ja) アルテアンヌイン−シクロデキストリン結合体及びその製造方法
KR101450838B1 (ko) 표적화 화학요법을 위한 암 인식 지능형 폴리펩티드 및 이의 제조방법
CA3026504A1 (en) Non-cleavable polymer conjugated with .alpha..nu..beta.3 integrin thyroid antagonists
Liu et al. Functionalized Nanoparticles Efficiently Enhancing the Targeted Delivery, Tumor Penetration, and Anticancer Activity of 7‐Ethyl‐10‐Hydroxycamptothecin
Huang et al. From small deferiprone to macromolecular micelles: self-assembly enhances iron chelation